|
Category:
Description:
Indications:
Contraindications:
-
Pregnancy and lactation
-
Undiagnosed abnormal vaginal bleeding
-
Known or suspected benign or malignant liver tumors while on oral
contraceptive use
- Breast carcinoma or estrogen-dependent neoplasia
-
Current or history of thromboembolic disorders, cerebral vascular or
cardiovascular disease.
Precautions:
-
Pregnancy category X
-
Take as directed at intervals not exceeding 24 hours.
Efficiency is dependent upon strict compliance.
-
Breakthrough bleeding (“spotting”) may occur during initiation of
therapy.
-
Use an alternate form of contraception during first month of initial
cycle.
-
Instructions for missed doses:
-
One missed dose: Take as soon as possible or two tablets the next
day and continue
-
Two missed doses: Take two tablets daily for two days, then
continue normal schedule
-
Three missed doses: Discontinue therapy and begin new packet 7
days following last dose
-
May cause mental depression, fluid retention and depressed folate
levels
-
Twenty-eight day packs contain seven days of inert ingredients to
maintain regimen
-
Begin therapy on the fifth day of the cycle.
Day one of cycle is the first day of menstrual bleeding.
Adverse Reactions (Side Effects):
-
Abdominal cramping, anorexia, nausea, vomiting
-
Acne
-
Edema, weight gain
-
Unusual tiredness or weakness
-
Cardiovascular disorders (hypertension)
-
Thromboembolic disorders
|
Dosage:
Administered orally
For more information on Oral Contraceptive Pills, read:
|
The information contained here is an
abbreviated summary. For more detailed and complete information, consult the
manufacturer's product information sheets or standard textbooks
Source:
Operational Medicine 2001, Health
Care in Military Settings, NAVMED P-5139, May 1, 2001, Bureau
of Medicine and Surgery, Department of the Navy, 2300 E Street NW, Washington,
D.C., 20372-5300
Military Obstetrics & Gynecology
© 2003, 2004, 2005, 2006
Medical Education Division,
Brookside Associates, Ltd.
All rights reserved
Other Brookside Products |